Lishu Li

1.5k total citations · 1 hit paper
8 papers, 1.1k citations indexed

About

Lishu Li is a scholar working on Physiology, Epidemiology and Rheumatology. According to data from OpenAlex, Lishu Li has authored 8 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 5 papers in Epidemiology and 4 papers in Rheumatology. Recurrent topics in Lishu Li's work include Lysosomal Storage Disorders Research (7 papers), Autophagy in Disease and Therapy (4 papers) and Glycogen Storage Diseases and Myoclonus (4 papers). Lishu Li is often cited by papers focused on Lysosomal Storage Disorders Research (7 papers), Autophagy in Disease and Therapy (4 papers) and Glycogen Storage Diseases and Myoclonus (4 papers). Lishu Li collaborates with scholars based in United States, Israel and Italy. Lishu Li's co-authors include Jeong‐A Lim, Nina Raben, Rosa Puertollano, José A. Martina, Heba I. Diab, Simona Patange, Rachel Myerowitz, Or Kakhlon, Andrea Ballabio and Erin Feeney and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Autophagy and Science Signaling.

In The Last Decade

Lishu Li

7 papers receiving 1.1k citations

Hit Papers

The Nutrient-Responsive Transcription Factor TFE3 Promote... 2014 2026 2018 2022 2014 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lishu Li United States 6 552 482 446 254 242 8 1.1k
Jeong‐A Lim United States 13 711 1.3× 650 1.3× 647 1.5× 324 1.3× 305 1.3× 23 1.6k
Shoichi Takikita United States 16 408 0.7× 556 1.2× 461 1.0× 117 0.5× 153 0.6× 25 1.1k
Jakub Sikora Czechia 20 182 0.3× 487 1.0× 507 1.1× 137 0.5× 186 0.8× 48 1.1k
Nina Raben United States 6 573 1.0× 200 0.4× 456 1.0× 128 0.5× 174 0.7× 6 942
Cindy van Roomen Netherlands 12 306 0.6× 682 1.4× 279 0.6× 39 0.2× 239 1.0× 14 1.0k
Alessia Lombardi Italy 13 187 0.3× 294 0.6× 235 0.5× 94 0.4× 183 0.8× 20 705
Antonio Díaz United States 14 632 1.1× 348 0.7× 558 1.3× 81 0.3× 389 1.6× 21 1.3k
Tina Rozaklis Australia 17 231 0.4× 659 1.4× 236 0.5× 44 0.2× 253 1.0× 24 835
Sandra Pohl Germany 19 167 0.3× 584 1.2× 601 1.3× 277 1.1× 407 1.7× 42 1.1k
Amparo Chabás Spain 26 435 0.8× 1.4k 2.9× 727 1.6× 82 0.3× 690 2.9× 90 1.8k

Countries citing papers authored by Lishu Li

Since Specialization
Citations

This map shows the geographic impact of Lishu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lishu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lishu Li more than expected).

Fields of papers citing papers by Lishu Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lishu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lishu Li. The network helps show where Lishu Li may publish in the future.

Co-authorship network of co-authors of Lishu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Lishu Li. A scholar is included among the top collaborators of Lishu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lishu Li. Lishu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Li, Yuan, et al.. (2023). Fluorochloridone induces mitochondrial dysfunction and apoptosis in primary goat Sertoli cells. Theriogenology. 214. 192–200. 2 indexed citations
2.
Lim, Jeong‐A, Lishu Li, Orian S. Shirihai, et al.. (2017). Modulation of mTOR signaling as a strategy for the treatment of Pompe disease. EMBO Molecular Medicine. 9(3). 353–370. 74 indexed citations
3.
Lim, Jeong‐A, Lishu Li, Or Kakhlon, Rachel Myerowitz, & Nina Raben. (2015). Defects in calcium homeostasis and mitochondria can be reversed in Pompe disease. Autophagy. 11(2). 385–402. 100 indexed citations
4.
Lim, Jeong‐A, Or Kakhlon, Lishu Li, Rachel Myerowitz, & Nina Raben. (2015). Pompe disease: Shared and unshared features of lysosomal storage disorders. PubMed. 3(1). e1068978–e1068978. 29 indexed citations
5.
Lim, Jeong‐A, Lishu Li, & Nina Raben. (2014). Pompe disease: from pathophysiology to therapy and back again. Frontiers in Aging Neuroscience. 6. 177–177. 148 indexed citations
6.
Martina, José A., Heba I. Diab, Lishu Li, et al.. (2014). The Nutrient-Responsive Transcription Factor TFE3 Promotes Autophagy, Lysosomal Biogenesis, and Clearance of Cellular Debris. Science Signaling. 7(309). ra9–ra9. 503 indexed citations breakdown →
7.
Spampanato, Carmine, Erin Feeney, Lishu Li, et al.. (2013). Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease. EMBO Molecular Medicine. 5(5). 691–706. 262 indexed citations
8.
Feeney, Erin, et al.. (2013). WITHDRAWN: Clearance of lysosomal glycogen accumulation by transcription factor EB (TFEB) in muscle cells from lysosomal alpha-glucosidase deficient mice. Biochemical and Biophysical Research Communications. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026